Abstract:Background & Objective: The objective of this study was to explore the risk factors for cognitive impairment in patients with cerebral small vessel disease (CSVD), and to construct a predictive model for cognitive impairment in CSVD patients, providing personalized diagnostic and treatment strategies for patients. Methods: Clinical data and blood indicators of CSVD patients admitted to the Department of Neurology at the Second Affiliated Hospital of Shandong First Medical University from February 2022 to February 2023 were collected. Additionally, these patients underwent cranial MRI examinations and completed neurological and psychological assessments, including the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). Based on the MoCA and MMSE results, the patients were divided into the cognitive impairment group and the normal cognitive group. Clinical data, blood indicators, and white matter lesion (WML) grades were compared between the two groups. Univariate logistic regression analysis was performed to identify the risk factors for cognitive impairment in CSVD patients. Using MoCA assessment results as the gold standard and several clinical indicators as independent variables, a logistic regression model was constructed. Predicted values were calculated based on this model, and a receiver operating characteristic (ROC) curve for the comprehensive diagnosis of multiple variables was plotted to evaluate the model’s accuracy. Results: A total of 134 CSVD patients were included, and cognitive impairment occurred in 98 cases, with an incidence rate of 73.13%, while 36 patients did not have cognitive impairment. Univariate logistic regression analysis of the collected variables identified eight factors: age, education level, hypertension, diabetes, cerebral hemorrhage, low-density lipoprotein cholesterol (LDL-C), hyperhomocysteine (HHCY), and WML grading. Multivariate logistic regression analysis identified age, LDL-C, and WML grading as the final predictive factors, establishing a combined diagnostic model to predict the probability of cognitive impairment in patients. The constructed ROC curve for the comprehensive diagnosis of multiple variables yielded an area under the curve of 0.870, indicating good accuracy. To facilitate clinical diagnosis, the combined diagnostic model was simplified into an L score calculation formula, with the optimal cutoff value of 5.223. When the L score is <5.223, the patient can be considered not having cognitive impairment, while an L score >5.223 indicates cognitive impairment, allowing for the prediction of the risk of cognitive impairment in patients. Conclusion: Age, education level, hypertension, diabetes, cerebral hemorrhage, LDL-C, HHCY, and WML grading are related risk factors for cognitive impairment in CSVD patients. Age, LDL-C, and WML grading are independent risk factors for cognitive impairment in CSVD patients. The clinical predictive model for cognitive impairment in cerebral small vessel disease, constructed using the final predictive factors, showed good performance and clinical utility. It facilitates individualized risk assessment for cognitive impairment in CSVD patients and allows for targeted follow-up observation for high-risk individuals.

Individualized prediction of cognitive test scores from functional brain connectome in patients with first-episode late-life depression

Effective and Accurate Diagnosis of Subjective Cognitive Decline Based on Functional Connection and Graph Theory View.

Connectome-based Predictive Modelling of Ageing, Overall Cognitive Functioning and Memory Performance.

Functional Connectome‐based Prediction of Individual Clinical and Cognitive Scores in Midlife Population with Risk of Dementia

Aberrant functional connectivity network in subjective memory complaint individuals relates to pathological biomarkers

Connectome-based predictive modelling estimates individual cognitive status in Parkinson's disease

Brain morphometric features predict depression symptom phenotypes in late-life depression using a deep learning model

Exploration of a Comprehensive Index for Predicting Cognitive Impairment in Patients with Cerebral Small Vessel Disease and White Matter Lesions

Connectome-based prediction of the severity of autism spectrum disorder

Predicting Treatment Selections for Individuals with Major Depressive Disorder According to Functional Connectivity Subgroups

Machine Learning Prediction of Treatment Outcome in Late-Life Depression

Cognitive Function Assessment and Prediction for Subjective Cognitive Decline and Mild Cognitive Impairment.

Feature Selection and Combination of Information in the Functional Brain Connectome for Discrimination of Mild Cognitive Impairment and Analyses of Altered Brain Patterns

Automatic diagnosis of late-life depression by 3D convolutional neural networks and cross-sample Entropy analysis from resting-state fMRI

Functional connectivity–based prediction of global cognition and motor function in riluzole-naive amyotrophic lateral sclerosis patients

Application of Structural and Functional Connectome Mismatch for Classification and Individualized Therapy in Alzheimer Disease

Individualized Prediction of Task Performance Decline Using Pre-Task Resting-State Functional Connectivity

Individual Proportion Loss of Functional Connectivity Strength: A Novel Individual Functional Connectivity Biomarker for Subjective Cognitive Decline Populations

Large-scale functional connectivity predicts cognitive impairment related to type 2 diabetes mellitus

Prediction of Cognitive Progression Due to Alzheimer's Disease in Normal Subjects Based on Individual Default Mode Network Metabolic Connectivity Strength

Identification of Major Depressive Disorder and Prediction of Treatment Response Using Functional Connectivity Between the Prefrontal Cortices and Subgenual Anterior Cingulate: A Real-World Study